Pembrolizumab+T3P-Y058-739 clinical trials

First in Human Study of T3P-Y058-739 (T3P)

This study is testing a new treatment, T3P, for advanced solid tumours. It's a first human trial, looking at how safe and effective T3P is, both alone and with another drug called pembrolizumab, in adults aged 18-74.